Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM

AIDS

Volumn 26, Issue 17, 2012, Pages 2185-2192

  Wentzensen, Nicolas ^a   Follansbee, Stephen ^b   Borgonovo, Sylvia ^b   Tokugawa, Diane ^c   Schwartz, Lauren ^a   Lorey, Thomas S ^c   Sahasrabuddhe, Vikrant V ^a   Lamere, Brandon ^d   Gage, Julia C ^a   Fetterman, Barbara ^c   Darragh, Teresa M ^e   Castle, Philip E ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c KAISER PERMANENTE   (United States)

^d DIVISION OF RESEARCH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f American Society of Clinical Pathology   (United States)

Author keywords

anal cancer screening; HIV; human papillomavirus; human papillomavirus mRNA; MSM; p16

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN E6; PROTEIN E7; PROTEIN P16; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER GRADING; CANCER SCREENING; CYTOLOGY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANAL CANAL; ANUS NEOPLASMS; BIOLOGICAL MARKERS; CALIFORNIA; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; GENOTYPE; HOMOSEXUALITY, MALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 84869505733     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328359f255     Document Type: Article

References (22)

1. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54:1026- 1034.
2. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101:1120-1130.
3. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13:487-500.
4. Wentzensen N. Screening for anal cancer: endpoints needed. Lancet Oncol 2012; 13:438-440.
5. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907.
6. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011; 103:368-383.
7. Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin- Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009; 52:239-247.
8. SwedishKA, Lee EQ, Goldstone SE. The changing picture of highgrade anal intraepithelial neoplasia in men who have sex with men: the effects of 10 years of experience performing highresolution anoscopy. Dis Colon Rectum 2011; 54:1003-1007.
9. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011; 119:5-19.
10. Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol 2011; 6:1083-1098.
11. Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 2011; 12:880-890.
12. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124:1626-1636.
13. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114- 2119.
14. Darragh TM, Tokugawa D, Castle PE, Follansbee S, Borgonovo S, Lamere BJ, et al. Interrater agreement of anal cytology. Cancer Cytopathol 2012.
15. Gage JC, Sadorra M, Lamere BJ, Kail R, Aldrich C, Kinney W, et al. Comparison of the cobas human papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests. J Clin Microbiol 2012; 50:61-65.
16. Wentzensen N, Schiffman M, Dunn ST, Zuna RE, Walker J, Allen RA, et al. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer 2009; 124:964-969.
17. Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, et al. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Res 2010; 70:8578-8586.
18. Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009; 4:52-56.
19. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
20. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001; 93:1054-1061.
21. Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE. How to evaluate emerging technologies in cervical cancer screening? Int J Cancer 2009; 125:2489-2496.
22. Gage JC, Ghosh A, Borgonovo S, Follansbee S, Wentzensen N, Gravitt PE, et al. A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection. Acta Cytol 2011; 55:364-367.